A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 496.44
C 32.98
GOOG 607.08
BAC 8.10
RIMM 15.60

Recently Added

CPIC 1.17
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.72

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.17
NBTH 12.50
IDVC 0.35
0.72 +0.03 (4.41%) ALXA

Click Here to Receive Instant E-mail and RSS Alerts


Trade ALXA now with

Stock Details

Last Trade:0.72 Change:+0.03 (4.41%) Prev Close:0.69 Open: 0.68 Days Range:0.68 – 0.74 52 Week Range: 0.51 - 1.91 Volume:45438 P/E: 72.00
EPS:0.01





Recent Blog Posts

Blog Posts on 01/23/12 at 3:39pm
Analysis Of Institutional 5% Ownership Filings Last Week In Healthcare Sector
Blog Posts on 01/05/12 at 8:36am
Analysis Of Institutional 5% Ownership Filings On Tuesday And Wednesday
Blog Posts on 12/27/11 at 3:13pm
Analysis Of Institutional 5% Ownership Filings On Friday
Blog Posts on 12/22/11 at 4:38pm
Twelve Biotech Picks For 2012
Blog Posts on 12/19/11 at 1:32pm
Alexa And Somaxon: 2 Distressed Biotechs On Sale And Up For Sale
Blog Posts on 12/14/11 at 11:30am
Alexza Pharmaceuticals: Forward Looking Approval Catalyst In Play
Blog Posts on 12/09/11 at 2:47pm
Alexza Pharmaceuticals: Is It A 'Dead Cat' Bounce If The Cat's Still Breathing?
Blog Posts on 12/08/11 at 9:07am
Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers
Blog Posts on 12/01/11 at 11:48am
5 Healthcare Companies With Holiday Catalysts
Blog Posts on 11/14/11 at 4:11am
5 Companies Awaiting FDA Approval Decisions In Q1 2012
Blog Posts on 08/09/11 at 2:11pm
Alexza's Agitation Drug Back Under Review - Trade the Upcoming Catalysts
Blog Posts on 07/28/11 at 8:36am
5 Healthcare Company Updates Released Wednesday
Blog Posts on 07/19/11 at 4:42pm
Alexza Pharmaceuticals: Stock Moving Events for Second Half 2011
Blog Posts on 06/30/11 at 4:01pm
6 Healthcare Companies With July Catalysts
Blog Posts on 06/24/11 at 6:34pm
Biotech Catalysts for Third Quarter
Blog Posts on 06/24/11 at 5:06pm
12 Rallying Stocks Under $5 Undervalued by Analysts
Blog Posts on 05/16/11 at 10:18am
Biotech: Some CRL Recipients to Consider
Blog Posts on 03/31/11 at 3:29am
Dow Nears 2011 Highs
Blog Posts on 03/16/11 at 1:59pm
All Eyes on Alexza as Company Prepares to Re-File Drug Application
Blog Posts on 01/19/11 at 3:39am
The Market Seems to Disagree With Alexza's Promising News
Blog Posts on 01/19/11 at 2:56am
A New Deal for Alexza Could Present Opportunity for Investors
Blog Posts on 01/06/11 at 10:58am
Biotech’s Top and Bottom 10 From 2010
Blog Posts on 12/03/10 at 3:34pm
Alexza Pharma Update: On Course with Behavioral Drug, But FDA Meeting Still Pending
Blog Posts on 10/17/10 at 8:39am
Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
Blog Posts on 10/12/10 at 11:30am
Analyst Calls: ALXA, APOL, AXP, CP, DV, DVA, VZ, WPO, WYNN ...
Blog Posts on 10/12/10 at 11:13am
Alexza's CRL Offers Long Term Investment Opportunity
Blog Posts on 10/11/10 at 10:12am
Several Scenarios Ahead of the FDA's Imminent Decision on Alexza
Blog Posts on 10/11/10 at 6:55am
Risks vs. Benefits in Holding Alexza Through Approval of AZ-004
Blog Posts on 10/03/10 at 9:47am
Alexza Pharmaceuticals: Hold, Sell, or Put?
Blog Posts on 09/20/10 at 6:44am
Biotechs With Room to Run